top of page
News
Chat
Insights
Portfolios
Education
About
Plans/Pricing
API/MCP
Trial Date of Q4 2023 in Proposed Scheduling Order in Vascepa Litigation
The parties filed their proposed scheduling order (attached) yesterday in AMRN's patent infringement case against Hikma and Health Net....
Apr 24, 2021
AMRN CEO Retiring, but Patent Litigations Remain
On April 12, 2021 AMRN announced that its long-time president and CEO, John Thero, will retire on August 1, 2021. Thero will be replaced...
Apr 12, 2021
Jump start your biotech due diligence
Get started →
Our platform helps you uncover your next biotech investment opportunity
bottom of page
